NIH Program Announcements

black-landd.jpg

  • Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
    (PA-18-837)
    Office of the Director, NIH
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Institute on Aging
    National Institute on Alcohol Abuse and Alcoholism
    National Institute of Allergy and Infectious Diseases
    National Institute of Biomedical Imaging and Bioengineering
    National Institute on Drug Abuse
    National Institute of Dental and Craniofacial Research
    National Institute of General Medical Sciences
    National Institute on Minority Health and Health Disparities
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    Application Receipt/Submission Date(s): Applications are accepted on a rolling basis at any time starting 30 days after the Open Date until the expiration date, unless otherwise noted in Institute specific language. Please consult with Scientific contacts listed in Section VII. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Enhancing Developmental Biology Research at Academic Research Enhancement Award Eligible Institutions (R15 – Clinical Trial Not Allowed)
    (PAR-18-834)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt/Submission Date(s): September 18, 2018, September 18, 2019, September 18, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)
    (PAR-18-835)
    John E. Fogarty International Center
    National Eye Institute
    National Institute on Aging
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Deafness and Other Communication Disorders
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): November 7, 2018; November 7, 2019,by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
    (PAR-18-836)
    John E. Fogarty International Center
    National Eye Institute
    National Institute on Aging
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Environmental Health Sciences
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    Application Receipt/Submission Date(s): November 7, 2018; November 7, 2019), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Advertisements
| Leave a comment

NIH Requests for Applications

black-landd.jpg

  • High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed)
    (RFA-AG-19-015)
    National Institute on Aging
    Application Receipt Date(s): February 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • High-Priority Behavioral and Social Research Networks in Alzheimer’s Disease and Alzheimer’s Disease Related Dementias (R24 Clinical Trial Not Allowed)
    (RFA-AG-19-016)
    National Institute on Aging
    Application Receipt Date(s): February 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed)
    (RFA-AI-18-026)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): December 13, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed)
    (RFA-CA-18-025)
    National Cancer Institute
    Application Receipt Date(s): August 28, 2018, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this FOA. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
| Leave a comment

NIH Notices

black-landd.jpg

  • Clarification: Assignment Deadlines for Applications Submitted Under the NIH Continuous Submission Policy
    (NOT-OD-18-178) Office of the Director, NIH
  • Notice of Correction to NOT-OD-18-174 “Notice of Intent to Publish a Funding Opportunity Announcement for the Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) Institutional Research Training Program [T32]”
    (NOT-OD-18-193) Office of the Director, NIH
  • Notice of Availability of Administrative Supplements for NIH Grants that are NOT Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives
    (NOT-OD-18-194) Office of the Director, NIH
    National Center for Advancing Translational Sciences
    National Center for Complementary and Integrative Health
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of General Medical Sciences
    National Institute of Mental Health
    National Institute on Minority Health and Health Disparities
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
  • Notice of Availability of Administrative Supplements for NIH Grants Focused on Down Syndrome to Address Specific Down Syndrome Research Objectives
    (NOT-OD-18-195) Office of the Director, NIH
    National Center for Advancing Translational Sciences
    National Cancer Institute
    National Eye Institute
    National Human Genome Research Institute
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Environmental Health Sciences
    National Institute of General Medical Sciences
    National Institute on Minority Health and Health Disparities
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
  • Notice to Extend the Expiration Date for PAR-15-350 “Emerging Directions for Addressing Health Disparities in Alzheimer’s Disease (R03)”
    (NOT-AG-18-015)
    National Institute on Aging
    National Institute of Dental and Craniofacial Research
    National Institute on Minority Health and Health Disparities
  • Notice to Extend the Expiration Date for PAR-15-357 “Understanding Alzheimer’s Disease in the Context of the Aging Brain (R01)”
    (NOT-AG-18-017)
    National Institute on Aging
  • Notice to Extend the Expiration Date for PAR-15-359 “Novel Approaches to Diagnosing Alzheimer’s Disease & Predicting Progression (R01)”
    (NOT-AG-18-019)
    National Institute on Aging
  • Notice to Extend the Expiration Date for PAR-18-027 “Research on Informal and Formal Caregiving for Alzheimer’s Disease (R01 Clinical Trial Optional)”
    (NOT-AG-18-020)
    National Institute on Aging
  • Notice to Extend the Expiration Date for PAR-18-179 “Research on Informal and Formal Caregiving for Alzheimer’s Disease (R21 Clinical Trial Optional)”
    (NOT-AG-18-021)
    National Institute on Aging
  • Notice of Clarification of NIA intent to fund awards for RFA-HL-18-023 “Stimulating Access to Research in Residency (StARR) (R38)”
    (NOT-AG-18-022)
    National Institute on Aging
  • Notice of Change to Eligible Organizations in NIAID PAR-18-335 Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)
    (NOT-AI-18-041)
    National Institute of Allergy and Infectious Diseases
  • Request for Information (RFI): Evaluation of the NIH Senator Paul D. Wellstone Muscular Dystrophy Research Centers Program
    (NOT-AR-18-021)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Heart, Lung, and Blood Institute
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute of Neurological Disorders and Stroke
  • Notice of Addition of Letter of Intent Due Dates on BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
    (NOT-EB-18-022)
    National Institute of Biomedical Imaging and Bioengineering
  • Strengthen Regulatory Systems to Ensure the Safety and Quality of Food and Medical Products (U01)
    (NOT-FD-18-012)
    Food and Drug Administration
  • Strengthening Global Competency and Capacity in Inspectional Approaches and Good Manufacturing Practices (GMP) (U01)
    (NOT-FD-18-013)
    Food and Drug Administration
  • Notice of U.S. Department of Agriculture (USDA) Participation in PAR-17-482 Comparative Genomics Research Program (R01)
    (NOT-HG-18-007)
    National Human Genome Research Institute
  • Notice of NIMH’s Interest in Studies of Neural Circuitry Linked to Computationally-Defined Behaviors of Relevance to Psychiatry in Rodents and Non-Human Primates
    (NOT-MH-18-036)
    National Institute of Mental Health
  • Notice of Clarification for Submission of Materials Related to Communications with the FDA for RFA-NS-18-011 “Translational Neural Devices (UG3/UH3 Clinical Trial Required)”
    (NOT-NS-18-063)
    National Institute of Neurological Disorders and Stroke
  • Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-012 “Translational Neural Devices (U44 Clinical Trial Required)”
    (NOT-NS-18-064)
    National Institute of Neurological Disorders and Stroke
  • Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-021 “BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3)”
    (NOT-NS-18-065)
    National Institute of Neurological Disorders and Stroke
  • Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-022 “BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44)”
    (NOT-NS-18-066)
    National Institute of Neurological Disorders and Stroke
  • Notice of Clarification for Submission of Materials Related to Communications with FDA for RFA-NS-18-023 “BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System”
    (NOT-NS-18-067)
    National Institute of Neurological Disorders and Stroke
  • Notice Regarding New Applications for PAR-15-303: “Occupational Safety and Health Education and Research Centers (42)”
    (NOT-OH-18-008)
    Centers for Disease Control and Prevention
  • Notice of Pre-Submission Webinars for RFA-TR-18-020: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional) and RFA-TR-18-021: Data Management and Coordinating Center (DMCC)
    (NOT-TR-18-029)
    National Center for Advancing Translational Sciences
| Leave a comment

Chaim Roifman Scholar Award for Senior Investigators Canadian Immunodeficiency Society

black-landd.jpg 28-Sep-2018 [LOI/Pre-App] 45,698.09 USD
Contact Email research@immunodeficiency.ca
Sponsor Website http://immunodeficiency.ca/
Program URL http://immunodeficiency.ca/healthcare-providers/research-grants/for-senior-investigators/
Deadline Dates (ALL) 28-Sep-2018 [LOI/Pre-App], 30-Nov-2018
Synopsis Immunodeficiency Canada annually requests proposals focused on research in primary immune deficiency (PI).
| Leave a comment

Promoting Aging In Place by Enhancing Access to Home Modifications Administration on Aging/DHHS

black-landd.jpg HHS-2018-ACL-AOA-HMOD-0308 13-Jul-2018 [Optional] [LOI/Pre-App] 750,000.00 USD
Contact Name Sherri Clark
Contact Email sherri.clark@acl.hhs.gov
Sponsor Website https://www.grants.gov/web/grants/view-opportunity.html?oppId=305883
Program URL https://www.acl.gov/grants/applying-grants
Deadline Dates (ALL) 13-Jul-2018 [Optional] [LOI/Pre-App], 13-Aug-2018
Synopsis Older adults overwhelmingly prefer to stay in their homes and communities as they age. But millions of older individuals live in homes that lack accessibility features that support the ability to live safely and independently. Falls are another major concern in the older adult populations. Most serious falls occur in and around the home, and can be life-changing. Home modifications and repairs can help older adults age in place and maintain their independence. In many cases home modifications can also help prevent falls and other accidents in the home. The Administration on Aging (AoA), an agency within the Administration for Community Living, intends to award one cooperative agreement designed to address barriers to optimal access to and use of home modifications that support aging in place. The project will be expected to provide technical assistance and serve as a repository for home modification best practices and innovations that can be replicated at the local level.
| Leave a comment

Toyota Foundation (Japan)

Research Grants
Contact Telephone 81-0 3-3344-1701
Sponsor Website http://www.toyotafound.or.jp/english/
Program URL http://www.toyotafound.or.jp/english/program/research.html
Deadline Dates (ALL) 03-Aug-2018
Synopsis The main topic of Research Grant Program 2018, titled “Exploring New Values for Society,” supports ambitious projects that adopt a panoramic view of the world and look generations into the future in order to seek new values for society by fundamentally exploring novel philosophies and arts to address difficult issues to be faced by future society; issues that are on a global scale; issues that transcend generations; and nascent problems that will only fully manifest themselves in the future.
| Leave a comment

Child Care Access Means Parents in School Program Office of Postsecondary Education/Department of Education

black-landd.jpg ED-GRANTS-061918-001 24-Jul-2018 0.00 USD
Contact Name Antoinette Clark Edwards
Contact Telephone 202- 453–7121
Contact Email antoinette.clark@ed.gov
Sponsor Website https://www.gpo.gov/fdsys/pkg/FR-2018-06-19/pdf/2018-13150.pdf
Program URL https://www.grants.gov/web/grants/search-grants.html
Deadline Dates (ALL) 24-Jul-2018
Synopsis The sponsor announces the availability of funds for the CCAMPIS Program, which supports the participation of low-income parents in postsecondary education through the provision of campus-based child care services.
| Leave a comment